摘要
背景:循环内皮细胞是来源于内皮祖细胞的成熟细胞,与血管壁无关,与内皮细胞分离。正常情况下,他们在正常人的外周血中不存在。另一方面,不同类型癌症和其他疾病患者外周血中CECs和EPCs水平升高。 目的:综述CECs和EPC的特性,描述其分离方法,探讨其在血液病和造血干细胞移植中的潜在作用。 方法:利用CECs、EPCs、异基因造血干细胞移植、血液学疾病(血红蛋白病、霍奇金和非霍奇金淋巴瘤、急性白血病、骨髓增生综合征、慢性淋巴细胞白血病)等相关关键词,对同侪文献进行详细检索。 结果:CECs和EPCs是治疗血液系统疾病等血管内皮细胞转换和重构的潜在生物标志物。这些细胞可能参与疾病的进展和肿瘤的过程。此外,内皮细胞和内皮细胞可能参与内皮损伤,这是异基因造血干细胞移植后并发症的一个标志。结论:本文综述了CECs和EPC在血液恶性肿瘤中的作用及其在预测疾病活动和改善HSCT预后中的意义。
关键词: 内皮祖细胞,循环内皮细胞,造血干细胞移植,急性白血病。
Current Medicinal Chemistry
Title:Endothelial and Circulating Progenitor Cells in Hematological Diseases and Allogeneic Hematopoietic Stem Cell Transplantation
Volume: 25 Issue: 35
关键词: 内皮祖细胞,循环内皮细胞,造血干细胞移植,急性白血病。
摘要: Background: Circulating endothelial cells (CECs), originated form endothelial progenitors (EPCs) are mature cells not associated with vessel walls and detached from the endothelium. Normally, they are present in insignificant amounts in the peripheral blood of healthy individuals. On the other hand, elevated CECs and EPCs levels have been reported in the peripheral blood of patients with different types of cancers and other diseases.
Objective: This review aims to provide an overview on the characterization of CECs and EPCs, to describe isolation methods and to identify the potential role of these cells in hematological diseases and hematopoietic stem cell transplantation.
Methods: We performed a detailed search of peer-reviewed literature using keywords related to CECs, EPCs, allogeneic hematopoietic stem cell transplantation, and hematological diseases (hemoglobinopathies, hodgkin and non-hodgkin lymphoma, acute leukemia, myeloproliferative syndromes, chronic lymphocytic leukemia).
Results: CECs and EPCs are potential biomarkers for several clinical conditions involving endothelial turnover and remodeling, such as in hematological diseases. These cells may be involved in disease progression and in the neoplastic process. Moreover, CECs and EPCs are probably involved in endothelial damage which is a marker of several complications following allogeneic hematopoietic stem cell transplantation.
Conclusion: This review provides information about the role of CECs and EPCs in hematological malignancies and shows their implication in predicting disease activity as well as improving HSCT outcomes.
Export Options
About this article
Cite this article as:
Endothelial and Circulating Progenitor Cells in Hematological Diseases and Allogeneic Hematopoietic Stem Cell Transplantation, Current Medicinal Chemistry 2018; 25 (35) . https://dx.doi.org/10.2174/0929867324666171012110244
DOI https://dx.doi.org/10.2174/0929867324666171012110244 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Targeting Sphingosine-1-Phosphate Receptors in Cancer
Anti-Cancer Agents in Medicinal Chemistry The Prospect of Stem Cells as Multi-Faceted Purveyors of Immune Modulation, Repair and Regeneration in Multiple Sclerosis
Current Stem Cell Research & Therapy Development of Novel Therapeutics Targeting Isocitrate Dehydrogenase Mutations in Cancer
Current Topics in Medicinal Chemistry Epigenetic Lesions in Malignant Melanoma
Current Pharmaceutical Biotechnology Perspectives in Medicinal Chemistry: DNA Methylation and Demethylation Mechanisms as Therapeutic Targets?
Current Topics in Medicinal Chemistry Large Granular Lymphocyte (LGL) Leukemia: Pathobiology, Diagnosis and Treatment
Current Cancer Therapy Reviews Phosphoinositide-3-kinases as the Novel Therapeutic Targets for the Inflammatory Diseases: Current and Future Perspectives
Current Drug Targets Functional Role of miR-34 Family in Human Cancer
Current Drug Targets ras Genes and Human Cancer: Different Implications and Different Roles
Current Genomics Promotion of Metastasis-associated Gene Expression in Survived PANC-1 Cells Following Trichostatin A Treatment
Anti-Cancer Agents in Medicinal Chemistry Flavonoid-Based Cancer Therapy: An Updated Review
Anti-Cancer Agents in Medicinal Chemistry CDC25 Inhibitors as Anticancer Agents Are Moving Forward
Anti-Cancer Agents in Medicinal Chemistry Lessons Learned from Two Decades of Clinical Trial Experience in Gene Therapy for Fanconi Anemia
Current Gene Therapy Paclitaxel Formulations: Challenges and Novel Delivery Options
Current Drug Delivery Serum miRNAs Signature Plays an Important Role in Keloid Disease
Current Molecular Medicine K-Ras, Intestinal Homeostasis and Colon Cancer
Current Clinical Pharmacology Current Guidelines and Strategies in Management of Renal Vein Thrombosis
Current Pediatric Reviews The Natural Tumor Suppressor Protein Maspin and Potential Application in Non Small Cell Lung Cancer
Current Pharmaceutical Design Oncogenic Fusion Tyrosine Kinases as Molecular Targets for Anti-Cancer Therapy
Anti-Cancer Agents in Medicinal Chemistry Dual Receptor-Specific Peptides Modified Liposomes as VEGF siRNA Vector for Tumor-Targeting Therapy
Current Gene Therapy